Clinical Trial

Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

Name: Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia — clinical trial record (NCT07733037)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PKU-ITP-FMT

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the safety and efficacy in immune thrombocytopenia patients receiving fecal microbiota transplantation

Trial Details

NCT Number	NCT07733037
Lead Sponsor	Peking University People's Hospital
Conditions	Immune Thrombocytopenia (ITP)
Enrollment	42 participants
Start Date	2026-01-10
Primary Completion	2026-12-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-29